Table 1 Proximity ligation assay reveals 11 tumor markers that are significantly elevated in pancreatic cancer cases compared to healthy controls.
Tumor Marker | p* < | Fold Difference†| Lower 95% CI | Upper 95% CI |
|---|---|---|---|---|
OPN | 1.20 × 10-12 | 2.04 | 14.99 | 15.38 |
CA19-9 | 6.82 × 10-12 | 16.41 | 17.57 | 18.55 |
CHI3L1 | 8.60 × 10-8 | 3.13 | 18.42 | 19.06 |
CA125 | 4.86 × 10-7 | 3.54 | 20.20 | 20.89 |
CEA | 1.35 × 10-5 | 3 | 17.70 | 18.35 |
VEGF | 3.22 × 10-4 | 2.17 | 14.04 | 14.65 |
MESO | 0.0014 | 1.39 | 20.63 | 20.92 |
IGF2 | 0.0022 | 1.35 | 21.45 | 21.78 |
IL-7 | 0.01 | 1.83 | 15.88 | 16.41 |
MIF | 0.01 | 1.58 | 16.35 | 16.88 |
ERBB2 | 0.02 | 1.18 | 18.57 | 18.84 |
EpCam | 0.04 | 0.63 | 12.85 | 13.35 |
EGFR | 0.07 | 0.89 | 16.58 | 16.85 |
IL-1 | 0.28 | 1.36 | 16.72 | 17.18 |
ADAM8 | 0.29 | 1.35 | 7.41 | 7.85 |
Galectin | 0.3 | 0.94 | 10.34 | 10.54 |
CTGF | 0.4 | 1.12 | 11.07 | 11.60 |
CPA1 | 0.46 | 1.07 | 12.06 | 12.38 |
TNF | 0.49 | 1.22 | 13.03 | 13.44 |
SLPI | 0.68 | 1.08 | 20.41 | 20.73 |
CA15-3 | 0.82 | 1.02 | 16.88 | 17.24 |